The high Latuda price resulted from patent exclusivity and limited alternatives
Key factors include: the drug shortages have been resolved (tirzepatide in October 2024, semaglutide in February 2025), FDA-approved versions are commercially available, and the agency has received over 775 adverse event reports linked to compounded versions, many involving dosing errors from multi-dose vials
The question is never just "can I take this?" The real question is "what happens at the biochemical level when I do, and how do I manage those interactions intelligently?" When people ask whether they can take berberine and tirzepatide together, most online resources give one of two answers: a flat "no" based on vague safety concerns, or a flat "yes" with no nuance whatsoever
Doctors may recommend checking blood pressure, blood sugar levels, and other markers to catch any issues early
Only after the trial ended did Pannell find out she was in the treatment group the entire time